Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3576287 | 1.00 | ALDH1A1 (0.47) | ALDH1A1POLBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL3574844 | 0.89 | POLB (0.41) | ALDH1A1POLBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL3565201 | 0.87 | SMN1; SMN2 (0.46) | ALDH1A1POLBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL3578459 | 0.83 | MEN1 (0.44) | ALDH1A1SMN1; SMN2MAPTRAB9AL3MBTL1 | |
| Bromide SCHEMBL3571795 | 0.82 | SMN1; SMN2 (0.48) | ALDH1A1POLBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL3585190 | 0.78 | SMN1; SMN2 (0.52) | SMN1; SMN2MEN1KMT2AADRB2ADRB1 | |
| SCHEMBL3576288 | 0.77 | POLB (0.44) | ALDH1A1POLBSMN1; SMN2MAPTRAB9A | |
| SCHEMBL3566335 | 0.75 | SMN1; SMN2 (0.51) | ALDH1A1POLBSMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL3574069 | 0.73 | SMN1; SMN2 (0.53) | POLBSMN1; SMN2L3MBTL1ADRB2ADRB1 | |
| SCHEMBL3573082 | 0.73 | MAOB (0.51) | ALDH1A1SMN1; SMN2MAPTL3MBTL1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7728005-B2 | Ether derivative | AJINOMOTO CO., INC. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20060270693-A1 | Ether derivative | AJINOMOTO CO., INC. (JP) | 2006-11-30 | — | — | US | disclosed |
| EP-1679296-A1 | ETHER DERIVATIVE | Ajinomoto Co., Inc. (JP) | 2006-07-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060270693-A1 | Ether derivative | UROD, IL5, IL17A | ALDH1A1 126/4885POLB 2803/4885SMN1; SMN2 891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.